Author： Bakshi Shlomo Chalifa-Caspi Vered Plaschkes Inbar Perevozkin Igor Gurevich Michael Schwartz Riki
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.4, 2013-04, pp. : 351-362
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Glatiramer acetate: Anaphylaxis: case report
Reactions Weekly, Vol. 1, Iss. 1058, 2005-01 ,pp. :
Glatiramer acetate good news for MS
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Glatiramer acetate: Alopecia: case report
Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. :
Glatiramer acetate for the treatment of multiple sclerosis
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. :